In a report to clients March 6, Stanley initiated coverage of IMP with a “Buy” rating and 12-month price target of $4.00, ...

Following the release of the company’s fourth quarter results, Ventum analyst Andrew Semple has cut his price target on ...

Following the company’s fourth quarter results, Desjardins analyst Gary Ho has raised his price target on CareRx Corp.

Its fourth quarter results are in the books and Raymond James analyst Michael W. Freeman still thinks there is money to be ...

In a research report to clients March 4, the analyst initiated coverage of CJT with a “Buy” rating and 12-month price target ...

The stock has taken it on the chin, but Ventum Capital Markets analyst Rob Goff says this is an opportunity for investors to ...

Following the company’s fourth quarter results, Beacon Securities analyst Russell Stanley has cut his price target on ...

Beacon Securities analyst Russell Stanley thinks Graham Corporation will benefit from Trump’s plans for the shipbuilding industry.

So says Beacon Securities analyst Gabriel Leung. On March 3, Leung initiated coverage of XX with a “Buy” rating and a ...

Following the company’s fourth quarter results, Ventum Capital Markets analyst Andrew Semple has cut his price target on ...

Following results that have sent the stock northward, Research Capital analyst Andre Uddin remains bullish on Eupraxia ...

In recent days, several has issued reports highlighting what they feel are undervalued plays in the Canadian tech space.